{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:12:26Z","timestamp":1791231146842,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ijwd.2016.11.008","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T15:46:45Z","timestamp":1482508005000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial"],"prefix":"10.1097","volume":"3","author":[{"given":"K.","family":"Balighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Z.","family":"Ghodsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Daneshpazhooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ghale-Baghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nasimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Azizpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijwd.2016.11.008_bb0005","first-page":"125","article-title":"Facial seborrheic dermatitis: a report on current status and therapeutic horizons","volume":"8","author":"Bikowski","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0010","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/AAC.00219-11","article-title":"Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis","volume":"55","author":"Carrillo-Mu\u00f1oz","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","article-title":"Seborrheic dermatitis: Etiology, risk factors, and treatments: Facts and controversies","volume":"31","author":"Dessinioti","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0025","first-page":"895","article-title":"An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis","volume":"10","author":"Elewski","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0030","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archderm.142.8.1066","article-title":"Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0035","first-page":"119","article-title":"Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0040","first-page":"25","article-title":"Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1468-3083.2004.00693.x","article-title":"Seborrheic dermatitis","volume":"18","author":"Gupta","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-4362.2003.01981.x","article-title":"Is topical metronidazole effective in seborrheic dermatitis? A double-blind study","volume":"42","author":"Koca","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMcp0806464","article-title":"Clinical practice. Seborrheic dermatitis","volume":"360","author":"Naldi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0060","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2011.02.032","article-title":"Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults","volume":"67","author":"Papp","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0065","first-page":"126","article-title":"Seborrheic dermatitis in clinical practice","volume":"102","author":"Rovelli","year":"2011","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.NPR.0000399717.56736.1e","article-title":"Seborrheic dermatitis: A clinical practice snapshot","volume":"36","author":"Schmidt","year":"2011","journal-title":"Nurse Pract"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0075","first-page":"125","article-title":"Seborrheic dermatitis: An overview","volume":"74","author":"Schwartz","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijwd.2016.11.008_bb0080","first-page":"1135","article-title":"Treatment of interdigital tinea pedis: Once-daily therapy with sertaconazole nitrate","volume":"10","author":"Weinberg","year":"2011","journal-title":"J Drugs Dermatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235264751630034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235264751630034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.ijwd.2016.11.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:23:54Z","timestamp":1789647834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.ijwd.2016.11.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S235264751630034X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2016.11.008","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}